Home / Companies / Catalyst Pharmaceuticals, Inc. / 20 May 2025
Catalyst Pharmaceuticals, Inc.: meeting of 20 May 2025
Votes reported on Form N-PX, item by item
515 Form N-PX filers reported votes at the Catalyst Pharmaceuticals, Inc. meeting of 20 May 2025. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
6 nominees; 95.9% of reported votes for; 25 filers withheld from or voted against at least one nominee.
2,150 vote records from 180 filers. 2 of the 180 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
877 vote records from 509 filers. 53 of the 493 filers that marked the item either way voted against management. 16 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
360 vote records from 180 filers. 3 of the 180 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
366 vote records from 183 filers. 8 of the 183 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
319 vote records from 150 filers. 148 of the 150 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
51 vote records from 31 filers. 14 of the 31 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Catalyst Pharmaceuticals, Inc. meeting?
515 Form N-PX filers reported votes at the meeting of 20 May 2025. On say-on-pay, 53 of 493 voted against management (10.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Catalyst Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Catalyst Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Catalyst Pharmaceuticals, Inc. with a meeting date within three days of 20 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.